The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10820 malaria professionals are enjoying the free benefits of MalariaWorld today

anti-malarial

Not Open Access | Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase

January 22, 2015 - 14:42 -- NOT Open Access
Author(s): 
Vitul Jain, Haruhisa Kikuchi, Yoshiteru Oshima, Amit Sharma, Manickam Yogavel
Reference: 
Journal of Structural and Functional Genomics, Volume 15, Issue 4, pp 181-190, December 2014

The structural analyses presented here provide a framework for development of febrifugine derivatives that can seed development of new anti-malarials.

Anti-malarial activity of a polyherbal product (Nefang) during early and established Plasmodium infection in rodent models

December 5, 2014 - 07:22 -- Open Access
Author(s): 
Protus Arrey Tarkang, Faith A Okalebo, Lawrence S Ayong, Gabriel A Agbor, Anastasia N Guantai
Reference: 
Malaria Journal 2014, 13:456 (25 November 2014)

This study aimed at investigating the suppressive, prophylactic and curative activities of Nefang in Plasmodium infected rodent models.

The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement

November 25, 2014 - 16:54 -- Open Access
Author(s): 
Miranda I Teboh-Ewungkem, Jemal Mohammed-Awel, Frederick N Baliraine, Scott M Duke-Sylvester
Reference: 
Malaria Journal 2014, 13:428 (15 November 2014)

A theoretical framework, as presented here, is thus relevant as the role of IPTi on accelerating the spread of drug resistance can be isolated in individual populations and when the populations are interconnected and interact.

Not Open Access | Synthesis, biological evaluation and molecular docking studies of tricyclic guanidine derivatives for anti-malarial activity

March 10, 2014 - 18:00 -- NOT Open Access
Author(s): 
Nafees Ahmed, Shabana I. Khan, Kamlesh K. Bhutani
Reference: 
Asian Pacific Journal of Tropical Disease, Volume 4, Issue 3, June 2014, Page 233

We have synthesized fifty tricyclic guanidine derivatives based on batzelladine K backbone. All synthesized compounds were evaluated for anti-malarial activity against chloroquine resistant strains of P. falciparum by using plasmodial LDH activity as measure of inhibition. 

Use of anti-malarial drugs and the risk of developing eye disorders

March 5, 2014 - 17:31 -- Open Access
Author(s): 
Cornelia Schneider, Miriam Adamcova, Susan S. Jick, Patricia Schlagenhauf, Mary K. Miller, Hans-Georg Rhein, Christoph R. Meier
Reference: 
Travel Medicine and Infectious Disease, Volume 12, Issue 1, January–February 2014, Pages 40-47

The study provides evidence that there was an increased risk of eye disorders in users of all anti-malarials compared to non-users of anti-malarials.

Anti-malarial activity and HS-SPME-GC-MS chemical profiling of Plinia cerrocampanensis leaf essential oil

January 21, 2014 - 17:42 -- Open Access
Author(s): 
Durant AA, Rodríguez C, Herrera L, Almanza A, Santana AI, Spadadora C, Gupta MP
Reference: 
Malaria Journal 2014, 13 :18 (13 January 2014)

Anti-malarial activity of the essential oil (EO) was evaluated in vitro against chloroquine-sensitive HB3 and chloroquine-resistant W2 strains of Plasmodium falciparum. Synergistic effect of chloroquine and the EO on parasite growth was evaluated by calculating the combination index.

Not Open Access | The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species

October 16, 2013 - 18:46 -- NOT Open Access
Author(s): 
Stella M. Chenet, M. Andreína Pacheco, David J. Bacon, William E. Collins, John W. Barnwell, Ananias A. Escalante
Reference: 
Infection, Genetics and Evolution, Volume 20, December 2013, Pages 239-248
MalariaWorld

Our findings suggest that the gene encoding MSP-9 is under purifying selection in P. vivax and closely related species.

Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate

October 14, 2013 - 18:53 -- Open Access
Author(s): 
Matthews H, Usman-Idris M, Khan F, Read M, Nirmalan N
Reference: 
Malaria Journal 2013, 12 :359 (9 October 2013)
MalariaWorld

This study reports the systematic and objective further interrogation of selected compounds reported in these studies, to enable their repositioning as novel stand-alone anti-malarials or as combinatorial partners.

The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana

August 5, 2013 - 15:11 -- Open Access
Author(s): 
Aborah S, Akweongo P, Adjuik M, Atinga RA, Welaga P, Adongo PB
Reference: 
Malaria Journal 2013, 12:266 (31 July 2013)
MalariaWorld

This study investigated the use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga Municipality of northern Ghana.

Country: 

Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda

July 23, 2013 - 16:25 -- Open Access
Author(s): 
Sears D, Kigozi R, Mpimbaza A, Kakeeto S, Sserwanga A, Staedke SG, Chang M, Kapella BK, Rubahika D, Kamya MR, Dorsey G
Reference: 
Malaria Journal 2013, 12:252 (19 July 2013)
MalariaWorld

Data for this report include patients with laboratory confirmed malaria who were prescribed anti-malarial therapy over a two-year period. Patient visits were analysed in two groups: those considered ACT candidates (defined as uncomplicated malaria with no referral for admission in patients >= 4 months of age and >= 5 kg in weight) and those who may not have been ACT candidates.

Country: 

Pages

Subscribe to RSS - anti-malarial